Elevated methylation of a stress response gene is identified in the blood of people manifesting suicidal behaviors and could be involved in suicide etiology.
Patients with both insomnia and depression saw improvement in symptoms of both disorders after being treated with cognitive-behavioral therapy for insomnia.
A new study from the National Institute of Mental Health supports the shift from DSM-IV to DSM-5 regarding the age-of-onset criterion for ADHD.
A new manual that updates the classification of sleep disorders rethinks the concept of insomnia and addresses a range of comorbid psychiatric illnesses as well as the effects of psychiatric drugs on sleep.
Though multiple medications have been developed for the treatment of patients with borderline personality disorder (BPD), none has yet gained formal approval.
Improving cognition and cognitive skills related to social functioning is a vital research area, since these variables are seen as major obstacles to improved daily functioning for people with schizophrenia.
Prescribing antidepressants in combination with mood stabilizers leads to better outcomes and fewer episodes of mania than prescribing only an antidepressant.
When choosing to stop antidepressant therapy during pregnancy, both physician and patient must balance the potential risks of treatment versus nontreatment.
Use of second-generation antipsychotics along with other medications is growing most rapidly among youth who are less impaired, but one expert cites the likely effect of the FDA warning about suicidality with antidepressant use by youth.
Read this week's Update
Sign Up for Psychiatric News Update newsletter